Mostrar el registro sencillo del ítem

Artículo

dc.creatorGarcía León, Juan Antonioes
dc.creatorVitorica Ferrández, Francisco Javieres
dc.creatorGutiérrez Pérez, Antoniaes
dc.date.accessioned2022-07-04T11:15:32Z
dc.date.available2022-07-04T11:15:32Z
dc.date.issued2019
dc.identifier.citationGarcía León, J.A., Vitorica Ferrández, F.J. y Gutiérrez Pérez, A. (2019). Use of human pluripotent stem cell-derived cells for neurodegenerative disease modeling and drug screening platform. Future Medicinal Chemistry, 11 (11), 1305-1322.
dc.identifier.issn1756-8919es
dc.identifier.issn1756-8927es
dc.identifier.urihttps://hdl.handle.net/11441/134962
dc.description.abstractMost neurodegenerative diseases are characterized by a complex and mostly still unresolved pathology. This fact, together with the lack of reliable disease models, has precluded the development of effective therapies counteracting the disease progression. The advent of human pluripotent stem cells has revolutionized the field allowing the generation of disease-relevant neural cell types that can be used for disease modeling, drug screening and, possibly, cell transplantation purposes. In this Review, we discuss the applications of human pluripotent stem cells, the development of efficient protocols for the derivation of the different neural cells and their applicability for robust in vitro disease modeling and drug screening platforms for most common neurodegenerative conditions.es
dc.formatapplication/pdfes
dc.format.extent18 p.es
dc.language.isoenges
dc.publisherFuture Science Groupes
dc.relation.ispartofFuture Medicinal Chemistry, 11 (11), 1305-1322.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAlzheimer’s diseasees
dc.subjectamyotrophic lateral sclerosises
dc.subjectCRISPR-Cas9es
dc.subjectdisease modelinges
dc.subjectdrug screeninges
dc.subjecthiPes
dc.titleUse of human pluripotent stem cell-derived cells for neurodegenerative disease modeling and drug screening platformes
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Bioquímica y Biología Moleculares
dc.relation.publisherversionhttps://doi.org/10.4155/fmc-2018-0520es
dc.identifier.doi10.4155/fmc-2018-0520es
dc.journaltitleFuture Medicinal Chemistryes
dc.publication.volumen11es
dc.publication.issue11es
dc.publication.initialPage1305es
dc.publication.endPage1322es
dc.identifier.sisius21865452es

FicherosTamañoFormatoVerDescripción
fmc-2018-0520.pdf1.082MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional